Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
XYL Stock Forecast 2026-2027
$119.98
Current Price
$29.17B
Market Cap
Buy 15
Hold 8
Sell 0
Wall St Analyst Ratings
Distance to XYL Price Targets
+55.0%
To High Target of $186.00
+31.7%
To Median Target of $158.00
+2.5%
To Low Target of $123.00
XYL Price Momentum
-4.2%
1 Week Change
-0.4%
1 Month Change
+7.4%
1 Year Change
-11.9%
Year-to-Date Change
-22.2%
From 52W High of $154.27
+12.1%
From 52W Low of $107.04
📊 TOP ANALYST CALLS
Did XYL Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Xylem is one of their latest high-conviction picks.
Latest XYL Stock Price Targets & Analyst Predictions
Based on our analysis of 27 Wall Street analysts, XYL has a bullish consensus with a median price target of $158.00 (ranging from $123.00 to $186.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $119.98, the median forecast implies a 31.7% upside. This outlook is supported by 15 Buy, 8 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Andrew Kaplowitz at Citigroup, suggesting a 2.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
XYL Analyst Ratings
15
Buy
8
Hold
0
Sell
XYL Price Target Range
Low
$123.00
Average
$158.00
High
$186.00
Current: $119.98
Latest XYL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for XYL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 16, 2026 | JP Morgan | Mark Strouse | Overweight | Maintains | $160.00 |
| Apr 14, 2026 | Stifel | Nathan Jones | Buy | Maintains | $163.00 |
| Apr 9, 2026 | UBS | Joshua Spector | Buy | Maintains | $152.00 |
| Apr 1, 2026 | Oppenheimer | Bryan Blair | Outperform | Reiterates | $160.00 |
| Mar 31, 2026 | Jefferies | Stephen Volkmann | Hold | Assumes | $130.00 |
| Feb 11, 2026 | Citigroup | Andrew Kaplowitz | Buy | Maintains | $174.00 |
| Feb 11, 2026 | Barclays | William Grippin | Overweight | Maintains | $156.00 |
| Feb 11, 2026 | RBC Capital | Deane Dray | Outperform | Maintains | $162.00 |
| Feb 11, 2026 | Stifel | Nathan Jones | Buy | Maintains | $175.00 |
| Jan 26, 2026 | William Blair | Brian Drab | Outperform | Initiates | $N/A |
| Jan 7, 2026 | Barclays | William Grippin | Overweight | Maintains | $166.00 |
| Jan 5, 2026 | Mizuho | Brett Linzey | Neutral | Maintains | $150.00 |
| Dec 5, 2025 | TD Cowen | Joseph Giordano | Hold | Maintains | $135.00 |
| Nov 6, 2025 | UBS | Damian Karas | Buy | Maintains | $175.00 |
| Oct 29, 2025 | Citigroup | Andrew Kaplowitz | Buy | Maintains | $182.00 |
| Oct 29, 2025 | Barclays | William Grippin | Overweight | Maintains | $172.00 |
| Oct 29, 2025 | RBC Capital | Deane Dray | Outperform | Maintains | $176.00 |
| Oct 29, 2025 | Stifel | Nathan Jones | Buy | Maintains | $178.00 |
| Oct 9, 2025 | Citigroup | Andrew Kaplowitz | Buy | Maintains | $173.00 |
| Sep 19, 2025 | Barclays | William Grippin | Overweight | Initiates | $165.00 |
Xylem Inc. (XYL) Competitors
The following stocks are similar to Xylem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Xylem Inc. (XYL) Financial Data
Xylem Inc. has a market capitalization of $29.17B with a P/E ratio of 30.8x. The company generates $9.03B in trailing twelve-month revenue with a 10.6% profit margin.
Revenue growth is +6.3% quarter-over-quarter, while maintaining an operating margin of +16.0% and return on equity of +8.4%.
Valuation Metrics
Market Cap
$29.17B
Enterprise Value
$30.55B
P/E Ratio
30.8x
PEG Ratio
19.8x
Price/Sales
3.2x
Growth & Margins
Revenue Growth (YoY)
+6.3%
Gross Margin
+38.9%
Operating Margin
+16.0%
Net Margin
+10.6%
EPS Growth
+2.8%
Financial Health
Cash/Price Ratio
+5.1%
Current Ratio
1.6x
Debt/Equity
21.1x
ROE
+8.4%
ROA
+4.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Xylem Inc. (XYL) Business Model
About Xylem Inc.
What They Do
Provider of water management solutions and products.
Business Model
The company generates revenue by designing, manufacturing, and servicing a range of engineered products for water management, including pumps, controls, and treatment technologies. By serving multiple sectors such as utilities, industrial, and residential markets, it addresses various water-related challenges and ensures efficient water transport and treatment.
Additional Information
Founded in 2011 and headquartered in Rye Brook, New York, Xylem Inc. has established a strong portfolio of well-known brands that contribute to its innovative solutions. The company is committed to sustainability and aims to provide effective solutions to global water issues.
Company Information
Sector
Industrials
Industry
Specialty Industrial Machinery
Employees
22,000
CEO
Mr. Matthew Francis Pine
Country
United States
IPO Year
2011
Website
www.xylem.comXylem Inc. (XYL) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Rollins Gears Up to Report Q1 Earnings: What's in the Cards?
ROL's Q1 revenues are expected to grow, driven by Orkin demand, digital tools and pricing strategies, but the model signals no clear beat.
Apr 21, 2026
By Zacks Equity Research
Analyst Blog
VLTO: Strong Fundamentals, but Growth Concerns Keep Outlook Balanced
Veralto shows strong fundamentals and market positioning, but modest growth, competition, and volatility keep investors in a cautious wait-and-watch mode.
Apr 20, 2026
By Zacks Equity Research
Analyst Blog
Equifax Set to Report Q1 Earnings: Here's What Investors Should Know
EFX gears up for the first-quarter 2026 results, with revenue growth expected across segments, but EPS is seen declining despite a solid mortgage-driven performance.
Apr 16, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Xylem (XYL) is expected to report earnings that may exceed analyst forecasts, based on favorable conditions identified ahead of the announcement.
Why It Matters
Xylem's potential earnings beat signals strong financial performance, likely boosting investor confidence and stock prices ahead of the report.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
AI data centers' increasing water consumption is projected to rise, potentially benefiting stocks like Xylem and American Water Works.
Why It Matters
Rising water consumption by AI data centers signals increased demand for water services, potentially boosting stocks like Xylem and American Water Works.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Zacks Premium research service offers Zacks Style Scores, aiding value, growth, and momentum investors in identifying strong stocks.
Why It Matters
Zacks Style Scores enhance stock selection for various investment strategies, potentially improving returns and guiding portfolio decisions for investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Xylem Inc. (NYSE: XYL) will release Q1 2026 results on April 28, 2026, at 6:55 a.m. ET, followed by an investor conference call at 9:00 a.m. ET. Access details are provided.
Why It Matters
Xylem Inc.'s upcoming earnings release and conference call are key indicators of financial performance and strategic direction, influencing investor sentiment and potential stock movement.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The NYSE has announced a daily pre-market update directly from its trading floor, effective March 19, 2026.
Why It Matters
The NYSE's pre-market advisory offers timely insights and market sentiment, influencing trading strategies and decision-making for investors.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Xylem Inc. (NYSE: XYL) has launched a $1.5 billion share repurchase program, effective immediately, to buy back its common stock on the open market or through private transactions.
Why It Matters
Xylem's $1.5 billion share repurchase program signals strong financial health and confidence in growth, likely boosting earnings per share and appealing to investors.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About XYL Stock
What is Xylem Inc.'s (XYL) stock forecast for 2026?
Based on our analysis of 27 Wall Street analysts, Xylem Inc. (XYL) has a median price target of $158.00. The highest price target is $186.00 and the lowest is $123.00.
Is XYL stock a good investment in 2026?
According to current analyst ratings, XYL has 15 Buy ratings, 8 Hold ratings, and 0 Sell ratings. The stock is currently trading at $119.98. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for XYL stock?
Wall Street analysts predict XYL stock could reach $158.00 in the next 12 months. This represents a 31.7% increase from the current price of $119.98. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Xylem Inc.'s business model?
The company generates revenue by designing, manufacturing, and servicing a range of engineered products for water management, including pumps, controls, and treatment technologies. By serving multiple sectors such as utilities, industrial, and residential markets, it addresses various water-related challenges and ensures efficient water transport and treatment.
What is the highest forecasted price for XYL Xylem Inc.?
The highest price target for XYL is $186.00 from at , which represents a 55.0% increase from the current price of $119.98.
What is the lowest forecasted price for XYL Xylem Inc.?
The lowest price target for XYL is $123.00 from Andrew Kaplowitz at Citigroup, which represents a 2.5% increase from the current price of $119.98.
What is the overall XYL consensus from analysts for Xylem Inc.?
The overall analyst consensus for XYL is bullish. Out of 27 Wall Street analysts, 15 rate it as Buy, 8 as Hold, and 0 as Sell, with a median price target of $158.00.
How accurate are XYL stock price projections?
Stock price projections, including those for Xylem Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 5:22 PM UTC